glp-1 medications mechanism of action Glucagon-like peptide-1 receptor: mechanisms and advances in therapy List of GLP-1 Receptor Agonists

37,38 A recent preclinical study investigated a combination therapy with semaglutide and bimagrumab

While the therapeutic benefits of GLP-1RAs in diabetes management are well-established, their emerging role in other diseases suggests novel treatment strategies

Accessed March 3, 2025

Friedman School of Nutrition Science and Policy at Tufts University, recently served as lead chair and author of a clinical advisory titled Nutritional Priorities to Support GLP-1 Therapy for Obesity, published across four peer-reviewed journals and issued by four leading organizations in lifestyle medicine, obesity medicine, and nutritionthe American College of Lifestyle Medicine (ACLM), the American Society for Nutrition (ASN), the Obesity Medicine Association (OMA), and The Obesity Society (TOS)

In: Katzung's Basic & Clinical Pharmacology

Please enable JavaScript to view this page.